Table 1.
Patient demographics, number, location, and clinical presentation of the vascular malformations
| Patient Number/Gender/Age (years) | Protocol Number | Vascular Malformation | Lesion Number | Lesion Location | Clinical Presentation | |
|---|---|---|---|---|---|---|
| with/without Gd (n=35) | with Fe (n=40) | |||||
| 1/F/57 | 1562 | Telangiectasia | 1 | 1 | Pons | Headaches |
| 2/M/67 | 1562 | Telangiectasia | 1 | 1 | Pons | Headaches |
| 3/F/46 | 1562 | Telangiectasia | 1 | 1 | Pons | Headaches |
| 4/M/31 | 1562 | Telangiectasia | 1 | 1 | Right Cerebellar Hemisphere | Headaches, Dizziness |
| 5/M/53 | 1562 | Telangiectasia | 1 | 1 | Pons | Incidental Finding (Brain Tumor Follow-Up) |
| 6/M/59 | 1562 | Telangiectasia | 0 | 1 | Mesencephalon | Incidental Finding (Brain Tumor Follow-Up) |
| 7/F/30 | 1562 | Telangiectasia | 1 | 3 | Mesencephalon, Right Basal Ganglia, Vermis | Headaches, Dizziness |
| Cavernoma | 2 | 2 | Mesencephalon | |||
| 8/F/43 | 1562 | Cavernoma | 1 | 1 | Medulla Oblongata | Left Facial Numbness and Pain |
| 9/M/33 | 1562 | Cavernoma | 15 | 17 | Bilateral Cerebral Hemispheres | Headaches |
| 10/F/63 | 1562 | Cavernoma | 2 | 2 | Right Frontal Lobe, Left Temporal Lobe | Headaches |
| 11/M/74 | 1562 | Cavernoma | 1 | 1 | Left Frontal Lobe | Incidental Finding (Brain Tumor Follow-Up) |
| 12/M/30 | 1562 | DVA | 1 | 1 | Left Frontal Lobe | Headaches |
| 13/F/72 | 1562 | DVA | 1 | 1 | Right Frontal Lobe | Headaches |
| 14/F/39 | 813 | DVA | 1 | 1 | Left Frontal Lobe | Incidental Finding (Brain Tumor Follow-Up) |
| 15/F/61 | 813 | DVA | 1 | 1 | Right Temporal Lobe | Incidental Finding (Brain Tumor Follow-Up) |
| 16/M/64 | 813 | DVA | 1 | 1 | Left Cerebellar Hemisphere | Incidental Finding (Brain Tumor Follow-Up) |
| 17/M/12 | 813 | DVA | 1 | 1 | Left Cerebellar Hemisphere | Incidental Finding (Brain Tumor Follow-Up) |
| 18/M/9 | 813 | DVA | 1 | 1 | Right Temporal Lobe | Incidental Finding (Brain Tumor Follow-Up) |
| 19/M/60 | 1562 | AVM | 1* | 1 | Spinal Cord | Bilateral Lower Extremity Weakness |
F, female; M, male; Gd, gadoteridol; Fe, ferumoxytol; DVA, developmental venous anomaly; AVM, arteriovenous malformation
*
The patient had chronic kidney disease, therefore only ferumoxytol was used.